ArticleBioactive materials2026
Low addition of Er and Zn into biomedical magnesium with enhanced integrated properties for orthopedic applications:
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the common alloying elements of Mg, rare earth elements (REEs) have been extensively explored due to their prominent effect on melt purification and mechanical strengthening. However, as for orthopedic applications, the only Mg-RE based implant that has received CE mark approval to date is developed from WE43 alloy, which contains substantial amount of REEs (4 wt% Y and 3 wt% mischmetal) and thus elicited biosafety concerns. Future advancement in novel Mg-RE based alloys is expected to reduce the amount of REEs along with its species. In this study, low amount of Er and Zn (≤3 wt%) were added into Mg. It came out that the addition of Er facilitated grain refinement while Zn contributed to the dynamic recrystallization of alloys. Compared to binary Mg-Er and Mg-Zn alloys, co-addition of Er and Zn could further strengthen the alloys. Among the alloys studied, Mg-1Er-1Zn alloy showed outstanding integrated performance, with relatively uniform corrosion pattern, superior mechanical properties and excellent osteogenic properties, indicating its potential for orthopedic applications. In light of these findings, it is recommended that optimized microstructure regulation and strict control on REEs addition be considered as crucial strategies for further development of novel Mg-RE-Zn alloys as orthopedic implants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.